BioBridgeXAll companies

Fennec Pharmaceuticals Inc.

Biotechnology company · Research Triangle Park, North Carolina, United States · Nasdaq: FENC

Fennec Pharmaceuticals Inc. is a biotechnology company headquartered in Research Triangle Park, North Carolina, United States. Its shares trade on Nasdaq under the ticker FENC. It has reported private securities offerings to the US SEC, most recently $7.6 million sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Fennec Pharmaceuticals at a glance

Typebiotechnology company
HeadquartersResearch Triangle Park, North Carolina, United States
Stock listingNasdaq: FENC
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1211583

What does Fennec Pharmaceuticals do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $7.6 million sold (2017).

Frequently asked questions about Fennec Pharmaceuticals

Where is Fennec Pharmaceuticals headquartered?

Fennec Pharmaceuticals Inc. is headquartered in Research Triangle Park, North Carolina, United States.

What does Fennec Pharmaceuticals do?

Fennec Pharmaceuticals Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Fennec Pharmaceuticals a public company?

Yes. Fennec Pharmaceuticals Inc. trades on Nasdaq under the ticker FENC.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences